Sucron Injection – Iron Sucrose Injection USP

Sucron Injection contains Iron Sucrose USP, a parenteral iron therapy indicated for the treatment of iron deficiency anemia (IDA) in patients where oral iron supplementation is ineffective or not tolerated. It provides a reliable source of bioavailable iron, helping restore hemoglobin levels and replenish iron stores rapidly. Sucron is administered intravenously under medical supervision, making it especially useful in patients with chronic kidney disease (CKD) or severe anemia.

Indications:

• Iron deficiency anemia (IDA)

• Anemia in chronic kidney disease patients (on dialysis or non-dialysis)

• Patients intolerant or unresponsive to oral iron therapy

• Post-surgical or chronic illness-related anemia

Key Benefits:

• Rapid correction of iron deficiency anemia

• High bioavailability with reliable iron absorption

• Safe and effective for patients intolerant to oral iron

• Supports hemoglobin synthesis and improves oxygen transport

• Improves energy levels and reduces anemia-related fatigue